MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
Sanne Løkkegaard, Daniel Elias, Carla L Alves, Martin V Bennetzen, Anne-Vibeke Lænkholm, Martin Bak, Morten F Gjerstorff, Lene E Johansen, Henriette Vever, Christina Bjerre, Tove Kirkegaard, Bo Nordenskjöld, Tommy Fornander, Olle Stål, Linda S Lindström, Laura J Esserman, Anne E Lykkesfeldt, Jens S Andersen, Rikke Leth-Larsen, Henrik J Ditzel
Dyk ned i forskningsemnerne om 'MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit'. Sammen danner de et unikt fingeraftryk.